LINE-X

LineX Therapeutics is a biotechnology company and a subsidiary of Applied DNA Sciences, focused on the development of linear DNA-based therapeutics. The company utilizes its proprietary LinearDNA platform to produce large-scale, high-purity DNA sequences for use in genetic vaccines and gene therapies. By moving away from traditional plasmid-based DNA production, LineX aims to reduce the risks of antibiotic resistance and genomic integration while improving manufacturing speed and scalability. Their current pipeline includes candidates for oncology and veterinary applications, leveraging the advantages of linear DNA in immune response and expression.